Advances in Biomimetic Apatite Coating on Metal Implants
C.Y. Zhao,H.S. Fan,X.D. Zhang
DOI: https://doi.org/10.5772/14938
2011-01-01
Abstract:Artificial implants are generally encapsulated by a fibrous tissue when implanted into bone defects. However, Hench et al. showed that bioglass directly bonded to living bone via a biologically active bone-like apatite layer instead of the formation of surrounding fibrous tissue(Hench et al., 1971). Meanwhile, with the mineral compositional resemblance with the inorganic phase of human bone, calcium phosphate ceramics possessed excellent biocompatibility and osteoconductivity, and it also showed bone-bonding ability via a biologically active bone-like apatite layer(W.P. Cao & Hench, 1996; Hench, 1998). Nowadays, they are both extensively used as hard tissue repair or substitution materials in clinic. However, these materials cannot be used under load-bearing conditions such as femur, tibia and spinal interbody, because they are usually very stiff and brittle, and have low impact resistance and relatively low tensile strength(Rezwan et al., 2006). Titanium and its alloys are widely used as orthopaedic implants due to their superior mechanical properties and excellent biocompatibility( X.Y. Liu et al., 2004; Ratner, 2001). However, their bioactivity are not as good as that of calcium phosphate ceramics and during implantation they can only form osteointegration at the interface of titanium and bone tissue, instead of bone-bonding(Feng et al., 2002). To overcome these disadvantages, various methods of coating the titanium surface have been developed to combine the mechanical properties of metals with bone-bonding ability of bioactive ceramics, such as ion-beam(Ong et al., 1992) or radiofrequency magnetron sputter deposition(Wolke et al., 1998), sol–gel method (Brendel et al., 1992; Weng & Baptista, 1999) et al, with plasma spraying being the most popular(Y. Cao et al., 1996; J. Chen et al., 1994). However, each of them has its own technical limitations, for example, the inability to coat those complex-shaped implants with internal cavities or porous implants and incorporate biologically active agents. Therefore, an optimal technique for apatite coatings on complex-shaped or porous implants still has to be developed. One alternative method is the so-called biomimetic apatite coating, which consists of mimicking the bone mineralization process by immersing implants in simulated body fluid (SBF) that mimics the inorganic composition, pH, and temperature of human blood plasma(Abe et al., 1990). As a result of the low temperature conditions of this technique, diverse Ca-P phases such as amorphous calcium phosphate (ACP), octacalcium phosphate (OCP) or carbonated apatite (CA), some of which are stable only at low temperatures, can be